自拍无码精品一区二区|亚洲А∨天堂久久精品|国产日韩欧美一区二区视|亚洲av高清dvd丝袜|中文一级无码黄片精品视频|亚洲无码网站在线免费观看|免费无码又爽又刺激又污又黄|成人免费无码婬片在线观看免费

159-2642-3062 027-65317797
服務(wù)熱線(工作日:9:00-17:30)

瀏覽量: 191

  • 產(chǎn)品名稱: Research Grade Dinutuximab ( 地努妥昔單抗 )
  • 產(chǎn)品貨號(hào): CSD00319
  • 貨期: 現(xiàn)貨
  • 價(jià)格與訂購: 2480
  • 數(shù)量:
    庫存: 100
  • 規(guī)格: 100μg
  • 產(chǎn)品信息
  • 如何訂購
    貨號(hào)(Catalog No.)
    CSD00319
    通用名INN
    Dinutuximab
    純度(Purity)
    >95%
    電泳圖(SDS-PAGE image)

    icon
    濃度( Concentration)
    1mg/ml
    Formulation
    PBS buffer PH7.5
    Source
    CHO cells
    內(nèi)毒素(Endotoxin level)
    Please contact with the lab for this information.
    產(chǎn)品描述(Description)
    Dinutuximab is an IgG1 monoclonal human/mouse chimeric antibody against GD2, a disialoganglioside expressed on tumors of neuroectodermal origin, including human neuroblastoma and melanoma, with highly restricted expression on normal tissues. It is composed of the variable heavy- and light-chain regions of the murine anti-GD2 mAb 14.18 and the constant regions of human IgG1 heavy-chain and kappa light-chain. By binding to GD2, dinutiximab induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity of tumor cells thereby leading to apoptosis and inhibiting proliferation of the tumour. It is indicated, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy. Despite a high clinical response seen after first-line treatment, the complete eradication of neuroblastoma is rarely achieved and the majority of patients with advanced disease suffer a relapse. Current strategies for treatment include immunotherapy with drugs such as dinutuximab to target surviving neuroblastoma cells and to prevent relapse.
    別名(Alternative names)
    14.18,MAb-14.18,MOAB Ch14.18
    靶點(diǎn);物種(Specificity target name;species)
    ganglioside GD2[Homo sapiens]
    種類(Species)
    Chimeric
    受體鑒定(Receptor identification)
    IgG1-kappa
    分子量(MV)
    145000.0 Da
    CAS
    1363687-32-4
    存儲(chǔ)條件(Storage)
    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
    Store at +4°C short term (1-2 weeks).
    Store at -20 °C 12 months.
    Store at -80°C long term.
    Note
    For research use only .
思南县| 潞西市| 泽库县| 务川| 扶余县| 东明县| 犍为县| 桃园县| 昭苏县| 沧州市| 渭南市| 峨眉山市| 宜宾市| 南丹县| 崇明县| 寿宁县| 哈巴河县| 新龙县| 长垣县| 翼城县| 九江市| SHOW| 海伦市| 罗定市| 新田县| 仁寿县| 海林市| 中宁县| 苍溪县| 柳河县| 嘉黎县| 阜康市| 天镇县| 偃师市| 雅安市| 姚安县| 浦东新区| 玉林市| 肇州县| 马鞍山市| 永济市|